HitGen Inc
SSE:688222

Watchlist Manager
HitGen Inc Logo
HitGen Inc
SSE:688222
Watchlist
Price: 12.07 CNY -7.08% Market Closed
Market Cap: 4.8B CNY
Have any thoughts about
HitGen Inc?
Write Note

HitGen Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HitGen Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
HitGen Inc
SSE:688222
Revenue
ÂĄ371.3m
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Revenue
ÂĄ38.7B
CAGR 3-Years
25%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Revenue
ÂĄ11.5B
CAGR 3-Years
23%
CAGR 5-Years
29%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Revenue
ÂĄ17.1B
CAGR 3-Years
28%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Revenue
ÂĄ6.8B
CAGR 3-Years
17%
CAGR 5-Years
20%
CAGR 10-Years
30%
W
WuXi XDC Cayman Inc
HKEX:2268
Revenue
ÂĄ2.1B
CAGR 3-Years
180%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

HitGen Inc
Glance View

Market Cap
4.8B CNY
Industry
Life Sciences Tools & Services

HitGen, Inc. engages in the provision deoxyribonucleic acid encoded compound library (DEL) for research and development of seed and lead compounds. The company is headquartered in Chengdu, Sichuan and currently employs 508 full-time employees. The company went IPO on 2020-04-16. The firm focuses on the research and creation of deoxyribonucleic acid encoded compound library (DEL) technology, research and development of hit compounds and lead compounds. The firm mainly provides DEL screening services, DEL library customization services, chemical synthesis services and transfer of new drug research and development projects. The firm conducts its businesses within the domestic market and to overseas markets.

Intrinsic Value
7.23 CNY
Overvaluation 40%
Intrinsic Value
Price

See Also

What is HitGen Inc's Revenue?
Revenue
371.3m CNY

Based on the financial report for Dec 31, 2023, HitGen Inc's Revenue amounts to 371.3m CNY.

What is HitGen Inc's Revenue growth rate?
Revenue CAGR 5Y
20%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for HitGen Inc have been 15% over the past three years , 20% over the past five years .

Back to Top